Cytopenia: Clinical Trials

1,555 trials for Cytopenia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

742 completed, 277 unknown, 199 recruiting, 136 terminated. 494 Phase 2, 283 Phase 3, 193 Phase 1, 164 Not applicable, 107 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 2494Completed 217, Unknown 82, Recruiting 64, Terminated 64, Not yet recruiting 26, Withdrawn 22, Active not recruiting 17, Enrolling by invitation 1, Suspended 1
Phase 3283Completed 156, Unknown 41, Terminated 31, Recruiting 22, Withdrawn 13, Active not recruiting 12, Not yet recruiting 8
Phase 1193Completed 107, Terminated 25, Recruiting 22, Unknown 13, Not yet recruiting 11, Withdrawn 8, Active not recruiting 5, Enrolling by invitation 2
Not applicable164Completed 72, Recruiting 26, Unknown 23, Not yet recruiting 19, Terminated 10, Withdrawn 8, Active not recruiting 6
Phase 4107Completed 44, Unknown 35, Recruiting 9, Terminated 9, Not yet recruiting 5, Withdrawn 5
Early Phase 121Recruiting 7, Completed 6, Unknown 4, Not yet recruiting 2, Withdrawn 2

Follow Cytopenia: new trials by email Literature Review of Cytopenia trials Research Report on Cytopenia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy
NM8074 - aHUS - Atypical Hemolytic Uremic Syndrome
Phase 2Not yet recruitingNovelMed Therapeutics122027-11-012026-04-13
Restrictive Versus Standard Antibiotic Treatment During CAR-T Therapy
ceftazidime, ciprofloxacin, Standard-of-Care Antibiotic Strategy - Large B-Cell Lymphoma (LBCL), Multiple Myeloma (MM)
Phase 2Not yet recruitingZealand University Hospital1502027-03-012026-09-25
G-CSF In Neonatal Sepsis With Neutropenia
Granulocyte-colony stimulating factor (G-CSF), Standard Sepsis Management - Neonatal Sepsis, Neutropenia
Not applicableNot yet recruitingUniversity of Health Sciences Lahore522027-02-152026-10-22
A Study of Ianalumab in Addition to Eltrombopag in Pediatric Patients With Primary ITP Who Failed Corticosteroids.
Ianalumab, Eltrombopag - Primary Immune Thrombocytopenia (ITP)
Phase 2Not yet recruitingNovartis Pharmaceuticals362027-02-082026-06-25
Phase 1 Dose Escalation Study of RXIM002 in Autoimmune Cytopenias
RXIM002 - Immune Thrombocytopenia (ITP)
Phase 1Not yet recruitingRiboX Therapeutics Ltd.272027-02-012026-09-23
A Study to Compare the Pharmacokinetics, Pharmacodynamics, Immunogenicity, Safety and Tolerability of Filgrastim Biosimilar and Neupogen Reference Product in Healthy Volunteers
Biofilgragen, Neupogen (filgrastim) - Neutropenia (Low White Blood Cell Count)
Phase 1Not yet recruitingBioGeneric Pharma502026-12-152026-10-20
Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma
Acupuncture - Febrile Neutropenia, Sarcoma
Not applicableNot yet recruitingShaare Zedek Medical Center602026-12-012026-04-29
A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA
Velinotamig specified dose on specified days. - Immune Thrombocytopenia (ITP), Warm Autoimmune Hemolytic Anemia (WAIHA)
Phase 1 / Phase 2Not yet recruitingCullinan Therapeutics Inc.722026-12-012026-07-31
Efficacy and Safety of Romiplostim N01 for Injection in Promoting Platelet Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation
Romiplostim N01 - Thrombocytopenia, Allogeneic Hematopoietic Stem Cell Transplantation
Phase 2Not yet recruitingThe First Affiliated Hospital of Henan University of Science and Technology872026-11-012026-09-21
TGD001 Treatment in Thrombotic Microangiopathies
TGD001 - Thrombotic Microangiopathies, ITP Immune-Mediated Thrombocytopenia
Phase 1 / Phase 2Not yet recruitingTargED Biopharmaceuticals B.V.702026-10-312026-09-29
Neonatal Thrombocytopenia in the NICU
Thrombocytopenia, Neonatal Thrombocytopenia
Not yet recruitingAssiut University1202026-10-202026-10-20
Effects of Resistance Training on Recovery During Hematopoietic Stem Cell Transplantation
8-week Elastic Band Resistance Training Program - Hematologic Malignancies, Hematopoietic Stem Cell Transplantation
Not applicableNot yet recruitingTaipei Veterans General Hospital, Taiwan862026-10-122026-10-14
Correlation Between ANC and Bone Pain in Breast Cancer Patients Receiving Long-Acting G-CSF
Breast Cancer, Chemotherapy-Induced Neutropenia
Not yet recruitingThe First Affiliated Hospital with Nanjing Medical University1322026-09-302026-09-08
A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Received Recombinant ADAMTS13 (rADAMTS13) as Part of the Early Access Program
No Intervention - Thrombotic Thrombocytopenic Purpura (TTP)
RecruitingTakeda942026-09-242026-10-20
Role of Viscoelastometric Testing in the Development and Validation of a Clinical-biological Score for Predicting Bleeding in Patients With Malignant Haematological Disorders and Severe Thrombocytopenia
Additional blood sample - Thrombocytopenia, Platelet Transfusion
RecruitingCentre Hospitalier Annecy Genevois4102026-09-182026-10-22
Predictive Score in Patients With Hematological Malignancies Colonized by Multidrug-resistant Enterobacteriaceae
Hemato-oncologic Patients, Colonization
Not yet recruitingFundación Pública Andaluza para la gestión de la Investigación en Sevilla5352026-09-042026-09-03
Autoimmune Cytopenia Elimination by Chimeric Antigen Receptor T-cell Therapy
AZD0120, Bendamustin - Cytopenia
Phase 1Not yet recruitingSaurabh Dahiya162026-09-012026-08-27
Selective Mediterranean Diet in Immune Thrombocytopenia
Selective Mediterranean Diet, Standard Pharmacological Therapy for ITP - Immune Thrombocytopenia, Idiopathic Thrombocytopenic Purpura
Not applicableNot yet recruitingAssiut University602026-09-012026-09-03
Clinical Study of CHT105 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases
CHT105 - Immune Thrombocytopenia (ITP)
Not applicableNot yet recruitingNanjing Miracle Biotechnology Co., Ltd.242026-09-012026-09-10
Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX)
Levofloxacin, Usual Care - Myeldysplastic Syndrome (MDS), MYELOPROLIFERATIVE DISORDER (P Vera, CMML, ET)
Phase 2Not yet recruitingUniversity of Manitoba752026-09-012026-06-29

Showing 20 of 1555. Sign in to see all of them.

Narrower conditions

Purpura, Thrombocytopenic, Idiopathic (481)  ·  Thrombocytopenia (409)  ·  Neutropenia (291)  ·  Febrile Neutropenia (143)  ·  Myelodysplastic Syndromes (66)  ·  Purpura, Thrombotic Thrombocytopenic (65)  ·  Neoplasms (64)  ·  Breast Neoplasms (61)  ·  Anemia (59)  ·  Hematologic Diseases (58)  ·  Leukemia, Myeloid, Acute (54)  ·  Thrombotic Microangiopathies (49)  ·  Hematologic Neoplasms (48)  ·  Fever (47)

Broader conditions

Hemic and Lymphatic Diseases (1555)  ·  Hematologic Diseases (1497)  ·  Blood Platelet Disorders (1002)  ·  Pathological Conditions, Signs and Symptoms (779)  ·  Pathologic Processes (724)  ·  Immune System Diseases (720)  ·  Signs and Symptoms (619)  ·  Thrombocytopenia (598)  ·  Blood Coagulation Disorders (597)  ·  Thrombotic Microangiopathies (588)  ·  Hemorrhagic Disorders (556)  ·  Skin Manifestations (548)  ·  Hemorrhage (543)  ·  Purpura (529)

Interventions

eltrombopag (106)  ·  romiplostim (54)  ·  Dexamethasone (49)  ·  Rituximab (48)  ·  Filgrastim (43)  ·  avatrombopag (41)  ·  pegfilgrastim (40)  ·  Cyclophosphamide (27)  ·  Immunoglobulins, Intravenous (21)  ·  Thrombopoietin (21)  ·  Blood Specimen Collection (20)  ·  Prednisone (19)  ·  Cyclosporine (16)  ·  eculizumab (15)  ·  Danazol (14)

Sponsors

Peking University People's Hospital (55)  ·  Shandong University (44)  ·  Amgen (43)  ·  Institute of Hematology & Blood Diseases Hospital, China (40)  ·  National Heart, Lung, and Blood Institute (NHLBI) (32)  ·  GlaxoSmithKline (29)  ·  Novartis Pharmaceuticals (27)  ·  Assistance Publique - Hôpitaux de Paris (26)  ·  Alexion Pharmaceuticals, Inc. (21)  ·  Assiut University (21)  ·  Pfizer (17)  ·  M.D. Anderson Cancer Center (16)  ·  Eisai Inc. (13)  ·  National Cancer Institute (NCI) (13)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (13)

Countries

United States (513)  ·  China (323)  ·  France (197)  ·  Italy (134)  ·  Germany (122)  ·  United Kingdom (117)  ·  Spain (109)  ·  Canada (89)  ·  Poland (71)  ·  Australia (70)  ·  South Korea (70)  ·  Netherlands (68)  ·  Belgium (56)  ·  Japan (54)  ·  Russia (53)

Top investigators

Lei Zhang, MD (18)  ·  Xiao-Hui Zhang, MD (14)  ·  Xiaohui Zhang, MD (10)  ·  Ming Hou, Dr (6)  ·  James Bussel, MD (5)  ·  Ming Hou (5)  ·  Ming Hou, Dr. (5)  ·  Cindy Leissinger, MD (4)

Results publications

PMID 33783815, PMID 19005182, PMID 19846889, PMID 29958797, PMID 39903535, PMID 40277027, PMID 19671919, PMID 23738544, PMID 24802773, PMID 29419434, PMID 29674506, PMID 32031570, PMID 32171076, PMID 34219224, PMID 34724566, PMID 24254965, PMID 26231455, PMID 26688484, PMID 29515037, PMID 33995988, PMID 35075289, PMID 12944568, PMID 17077333, PMID 18242413, PMID 19549917, PMID 20546023, PMID 21533818, PMID 22067384, PMID 22117897, PMID 22409309, PMID 22494019, PMID 23053510, PMID 23293082, PMID 23317527, PMID 23470153, PMID 23492914, PMID 24802775, PMID 25566808, PMID 26480931, PMID 27658437, PMID 27734464, PMID 28637287, PMID 29042367, PMID 29536526, PMID 29778606, PMID 30900158, PMID 30992268, PMID 32047671, PMID 33031789, PMID 33275766

NIH funding

2023 (15), 2014 (10), 2018 (10), 2019 (7), 2016 (6), U01HL072268 (6), 2009 (5), 2017 (4), 2025 (4), P30CA016672 (3), 2015 (2), P01HL046925 (2), P30CA015083 (2), P30CA015704 (2), U10CA095861 (2)